Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

USA - NYSE:BXC - US09624H2085 - Common Stock

71.46 USD
-1.57 (-2.15%)
Last: 10/10/2025, 12:25:35 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BXC. BXC was compared to 49 industry peers in the Trading Companies & Distributors industry. BXC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BXC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BXC was profitable.
In the past year BXC had a positive cash flow from operations.
BXC had positive earnings in each of the past 5 years.
BXC had a positive operating cash flow in each of the past 5 years.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of BXC (1.79%) is worse than 61.22% of its industry peers.
Looking at the Return On Equity, with a value of 4.57%, BXC is in line with its industry, outperforming 42.86% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.08%, BXC is doing worse than 69.39% of the companies in the same industry.
BXC had an Average Return On Invested Capital over the past 3 years of 11.49%. This is in line with the industry average of 10.03%.
The last Return On Invested Capital (3.08%) for BXC is well below the 3 year average (11.49%), which needs to be investigated, but indicates that BXC had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROIC 3.08%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

BXC has a worse Profit Margin (0.96%) than 61.22% of its industry peers.
BXC's Profit Margin has declined in the last couple of years.
The Operating Margin of BXC (2.09%) is worse than 71.43% of its industry peers.
BXC's Operating Margin has improved in the last couple of years.
The Gross Margin of BXC (15.94%) is worse than 87.76% of its industry peers.
In the last couple of years the Gross Margin of BXC has grown nicely.
Industry RankSector Rank
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

7

2. Health

2.1 Basic Checks

BXC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BXC has been reduced compared to 1 year ago.
The number of shares outstanding for BXC has been reduced compared to 5 years ago.
The debt/assets ratio for BXC has been reduced compared to a year ago.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.47 indicates that BXC is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.47, BXC is doing good in the industry, outperforming 63.27% of the companies in the same industry.
BXC has a Debt/Equity ratio of 0.96. This is a neutral value indicating BXC is somewhat dependend on debt financing.
The Debt to Equity ratio of BXC (0.96) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.47
ROIC/WACC0.34
WACC9.14%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.55 indicates that BXC has no problem at all paying its short term obligations.
BXC has a better Current ratio (4.55) than 93.88% of its industry peers.
BXC has a Quick Ratio of 2.94. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
BXC's Quick ratio of 2.94 is amongst the best of the industry. BXC outperforms 97.96% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 2.94
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -63.76% in the last year.
Measured over the past years, BXC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -40.26% on average per year.
The Revenue has decreased by -2.32% in the past year.
The Revenue has been growing slightly by 2.28% on average over the past years.
EPS 1Y (TTM)-63.76%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-58.33%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%1.53%

3.2 Future

The Earnings Per Share is expected to decrease by -24.98% on average over the next years. This is quite bad
The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y-76.57%
EPS Next 2Y-24.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.87%
Revenue Next 2Y2.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

BXC is valuated rather expensively with a Price/Earnings ratio of 20.24.
61.22% of the companies in the same industry are more expensive than BXC, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BXC to the average of the S&P500 Index (27.70), we can say BXC is valued slightly cheaper.
The Price/Forward Earnings ratio is 19.90, which indicates a rather expensive current valuation of BXC.
BXC's Price/Forward Earnings is on the same level as the industry average.
BXC is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.15, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.24
Fwd PE 19.9
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BXC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BXC is cheaper than 79.59% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.08
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as BXC's earnings are expected to decrease with -24.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (10/10/2025, 12:25:35 PM)

71.46

-1.57 (-2.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners96.47%
Inst Owner Change0%
Ins Owners2.21%
Ins Owner Change0.56%
Market Cap563.82M
Analysts77.5
Price Target83.64 (17.04%)
Short Float %5.94%
Short Ratio4.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.89%
Min EPS beat(2)-24.67%
Max EPS beat(2)0.88%
EPS beat(4)3
Avg EPS beat(4)13.48%
Min EPS beat(4)-24.67%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)23.04%
EPS beat(12)8
Avg EPS beat(12)14.37%
EPS beat(16)12
Avg EPS beat(16)22.17%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-1.23%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-2.07%
Revenue beat(12)2
Avg Revenue beat(12)-3.74%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)0%
PT rev (3m)-10.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-48.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-51.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.9%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-1.8%
Valuation
Industry RankSector Rank
PE 20.24
Fwd PE 19.9
P/S 0.19
P/FCF N/A
P/OCF 28.42
P/B 0.91
P/tB 1.04
EV/EBITDA 8.08
EPS(TTM)3.53
EY4.94%
EPS(NY)3.59
Fwd EY5.02%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)2.51
OCFY3.52%
SpS373.54
BVpS78.75
TBVpS68.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROCE 4.59%
ROIC 3.08%
ROICexc 4.33%
ROICexgc 4.73%
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
FCFM N/A
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexcg growth 3Y-37.08%
ROICexcg growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score3
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 6
Cap/Depr 115.37%
Cap/Sales 1.48%
Interest Coverage 1.33
Cash Conversion 19.97%
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 2.94
Altman-Z 3.47
F-Score3
WACC9.14%
ROIC/WACC0.34
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-63.76%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-58.33%
EPS Next Y-76.57%
EPS Next 2Y-24.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%1.53%
Revenue Next Year0.87%
Revenue Next 2Y2.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.23%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year-5.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.85%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-95.59%
OCF growth 3Y-16.25%
OCF growth 5YN/A